European Union - English - EMA (European Medicines Agency)

gilead sciences international limited - cidofovir - cytomegalovirus retinitis - antivirals for systemic use - vistide is indicated for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (aids) and without renal dysfunction. vistide should be used only when other agents are considered unsuitable.,

Israel - English - Ministry of Health

raz pharmaceutics ltd, israel - cidofovir as dihydrate - concentrate for solution for infusion - cidofovir as dihydrate 75 mg - cidofovir - cidofovir is indicated for the treatment of cmv retinitis in adults with acquired immunodeficiency syndrome (aids) and without renal dysfunction. it should be used only when other medicinal products are considered unsuitable.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences international ltd - cidofovir - solution for infusion - 75mg/1ml

Canada - English - Health Canada

marcan pharmaceuticals inc - cidofovir (cidofovir dihydrate) - solution - 375mg - cidofovir (cidofovir dihydrate) 375mg - nucleosides and nucleotides

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (united states - cidofovir - solution for infusion - 75mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - cidofovir - solution for infusion - 75mg/1ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tillomed pharma gmbh - cidofovir dihydrate 84,679 mg/ml - eq. cidofovir 75 mg/ml - concentrate for solution for infusion - 75 mg/ml - cidofovir dihydrate 84.679 mg/ml - cidofovir